Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerazette pretreatment before Nexplanon insertion for prediction of bleeding pattern
2011-001492-39Phase 4Completed
- Sponsor
- VL-Medi
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in contraception comparing Cerazette pretreatment then Nexplanon with Direct Nexplanon insertion control (2 arms). Primary endpoint: Total number of bleeding days per 90-day reference period. Started Jun 2011; status: completed.
02
Drugs
desogestreletonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2011-001492-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001492-39.